Targeting the endothelin receptor in prostate cancer bone metastasis Back to the mouse?

被引：3
作者：
Roh, Meejeon [1 ]
Abdulkadir, Sarki A. [1 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA
来源：
CANCER BIOLOGY & THERAPY | 2010年 / 9卷 / 08期
关键词：
atrasentan; endothelin; bone metastasis; prostate cancer; mouse model; CONTROLLED-TRIAL; IN-VIVO; EMERGING ROLE; ATRASENTAN; GROWTH; MEN; NEOVASCULARIZATION; ANTAGONIST; BLOCKADE; EFFICACY;
D O I：
10.4161/cbt.9.8.11309
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：615 / 617
页数：3
相关论文
共 50 条
  • [31] Clinical usefulness of bone markers in prostate cancer with bone metastasis
    Kamiya, Naoto
    Suzuki, Hiroyoshi
    Endo, Takumi
    Yano, Masashi
    Naoi, Makito
    Nishimi, Daisuke
    Kawamura, Koji
    Imamoto, Takashi
    Ichikawa, Tomohiko
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 (11) : 968 - 979
  • [32] Atrasentan: The first endothelin receptor antagonist for hormone-refractory prostate cancer
    Schulman, C
    EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (03) : 20 - 27
  • [33] Mouse models of breast cancer metastasis to bone
    Kelsi L. Kretschmann
    Alana L. Welm
    Cancer and Metastasis Reviews, 2012, 31 : 579 - 583
  • [34] Targeting tumor and bone microenvironment: Novel therapeutic opportunities for castration-resistant prostate cancer patients with bone metastasis
    Li, Shenglong
    Kang, Yue
    Zeng, Yu
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (01):
  • [35] Role of Interleukin-1 family in bone metastasis of prostate cancer
    Tong, Yuanhao
    Cao, Yinghao
    Jin, Tianzhe
    Huang, Zhengwei
    He, Qinyuan
    Mao, Min
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [36] Significance of serum osteoprotegerin and receptor activator of nuclear factor κB ligand in Japanese prostate cancer patients with bone metastasis
    Kamiya, Naoto
    Suzuki, Hiroyoshi
    Endo, Takumi
    Takano, Makoto
    Yano, Masashi
    Naoi, Makito
    Kawamura, Koji
    Imamoto, Takashi
    Takanami, Masaharu
    Ichikawa, Tomohiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2011, 16 (04) : 366 - 372
  • [37] Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis
    Conley-LaComb, M. Katie
    Semaan, Louie
    Singareddy, Rajareddy
    Li, Yanfeng
    Heath, Elisabeth I.
    Kim, Seongho
    Cher, Michael L.
    Chinni, Sreenivasa R.
    MOLECULAR CANCER, 2016, 15
  • [38] P2X7 receptor in prostate cancer bone metastasis initiating cells
    Arredondoo, H. M.
    Eaton, C. L.
    Wang, N.
    PURINERGIC SIGNALLING, 2018, 14 : S13 - S13
  • [39] Prostate Cancer Phenotype Influences Bone Mineralization at Metastasis: A Study Using an In Vitro Prostate Cancer Metastasis Testbed
    Molla, M. D. Shahjahan
    Katti, Dinesh R.
    Iswara, Jairam
    Venkatesan, Renugopalakrishnan
    Paulmurugan, Ramasamy
    Katti, Kalpana S.
    JBMR PLUS, 2020, 4 (02)
  • [40] Effects of Analgesics on Tumor Growth in Mouse Models of Prostate Cancer Bone Metastasis
    Xu, Jiajie J.
    Thurston, Sarah E.
    Robinson, Tyler J.
    Escara-Wilke, June F.
    Daignault-Newton, Stephanie
    Martin, Tara L.
    Keller, Evan T.
    Keller, Jill M.
    JOURNAL OF THE AMERICAN ASSOCIATION FOR LABORATORY ANIMAL SCIENCE, 2021, 60 (03): : 341 - 348
12345